Form 4: Heartflow Director Acquires Stock Options

Heartflow, Inc. director Jeffrey C. Lightcap acquired 16,075 stock options with an exercise price of $32.05.

Summary

• Jeffrey C. Lightcap, a director at Heartflow, Inc., was granted 16,075 stock options on June 16, 2026.
• The exercise price for these options is $32.05 per share.
• These options are set to vest in full on the earlier of the day before Heartflow, Inc.'s 2027 annual shareholder meeting or the first anniversary of the grant date, provided service continues.
• The transaction was reported on June 18, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard stock option grant to a director, which is typical compensation and incentive alignment rather than a significant new development.

Positives

• Director acquisition of stock options can signal confidence in the company's future prospects.
• The grant of options indicates a potential for future equity value growth for the director.

Risks

• The value of the stock options is contingent on the future performance of Heartflow, Inc.'s stock price exceeding the exercise price of $32.05.
• Vesting is subject to continued service, meaning the options could be forfeited if the director leaves the company before the vesting date.

Future Outlook

The stock options granted to the director are exercisable at $32.05 and will vest in full on the earlier of the day prior to Heartflow, Inc.'s annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service.

Industry Context

StockSavvy.ai notes that the granting of stock options to directors is a common practice in the biotechnology and medical technology sectors, aligning executive incentives with shareholder value creation. This type of transaction is standard for companies like Heartflow, Inc. as they navigate growth and development phases.

Stakeholder Impact

• Shareholders: The grant of options does not immediately dilute share count but represents potential future dilution if exercised. It can also be seen as a positive signal of management confidence.
• Employees: Standard compensation practice for directors, not directly impacting most employees.
• Management: Aligns director incentives with company performance.

Next Steps

• The stock options will vest according to the specified schedule.
• The director may exercise the options if the stock price exceeds $32.05 after vesting.

Key Dates

Keywords

Heartflow, Inc., HTFL, Form 4, Stock Options, Director, Beneficial Ownership, SEC Filing, Insider Trading